|
Summary:
Supply Of Biosimillary Drugs Country:
Spain Estimated Cost:
EUR 588803 Notice Type:
Tender Notice Deadline:
04 Sep 2025 Posting Date:
22 Aug 2025 |
|
Summary:
Completion Not Excl. Pharmaceutical Discount Club. According To Section 130A (8) Sgb V By An Open House Model To The Active Ingredient Denosumab-Reference: Prolia (Atc Code According To Who: M05Bx04) Country:
Germany
Notice Type:
Tender Notice Deadline:
31 Aug 2026 Posting Date:
09 Jul 2025 |
|
Summary:
Completion Not Excl. Pharmaceutical Discount Club. According To Section 130A (8) Sgb V By An Open House Model To The Active Ingredient Denosumab-Reference: Xgeva (Atc Code According To Who: M05Bx04) Country:
Germany
Notice Type:
Tender Notice Deadline:
31 Aug 2026 Posting Date:
09 Jul 2025 |
|
Summary:
Environmentally Friendly Supply Of Biological Human Medicines With Biosimilars For Public Health Centres In Valencia Country:
Spain Estimated Cost:
EUR 402393949 Notice Type:
Tender Notice Deadline:
01 Oct 2025 Posting Date:
30 Dec 2024 |
|
Summary:
Environmentally Friendly Supply Of Biological Human Medicines With Biosimilars For Public Health Centres In Valencia Country:
Spain Estimated Cost:
EUR 402393949 Notice Type:
Tender Notice Deadline:
01 Oct 2025 Posting Date:
30 Dec 2024 |
Biosimilar Pharmacovigilance Services Tenders and Contracts
Biosimilar Pharmacovigilance Services tenders contracts bids and business opportunities -
Healthcare and Medicine